Programme

New insights on progression in multiple sclerosis

8:30 Welcome breakfast

8:50 Introduction

• Clinical progression in multiple sclerosis
• Chaired by Bruno Brochet, Bordeaux and Aurélie Ruet, Bordeaux

• 9:00-9:35: Diagnosis and prognosis markers at the early stage of MS
  Georgina Arrambide, Barcelona
• 9:35-10:10: Assessing progression in MS
  Aurélie Ruet, Bordeaux

• Biological mechanisms of progression
  Neuroinflammation and remyelination mechanisms
• Chaired by Nathalie Schmitt, Bordeaux and Brahim Nait Oumesmar, Paris

• 10:15-10:40: The adaptive immune system in MS
  Laure Michel, Nantes
• 10h:40-11:05: The meningeal inflammation in MS
  Roberta Magliozzi, Verona

11:05-11:30 Coffee break

• Chaired by Stéphane Oliet, Bordeaux and Agnès Nadjar, Bordeaux

• 11:30-11:55: Axon-glial interactions and demyelinating diseases
  Thomas Tourdias, Bordeaux
• 11:55-12:20: Axonal microdomains on myelinated fibers and myelin plasticity
  Anne Desmazières, Paris
• 12:20-12:45: Biology of remyelination
  Violetta Zujovic, Paris

12:45-14:00 Lunchtime

• Bridging the gap between disease mechanisms and neuroimaging
• Chaired by Thomas Tourdias, Bordeaux and Françoise Durand-Dubief, Bron

• 14:00-14:25: MRI markers of progression in MS
  Declan T. Chard, London
• 14:25-14:50: Brain plasticity and repair
  Bertrand Audoin, Marseille
• 14:50-15:15: Insights from molecular imaging
  Benedetta Bodini, Paris

15:15-15:45 Coffee break

• Therapeutic perspectives
• Chaired by Declan T. Chard, London and Bruno Stankoff, Paris

• 15:45-16:10: Role of disease modifiers treatment on the progression in MS
  Emmanuelle Le Page, Rennes
• 16:10-16:35: Updates on neuroprotection
  Étienne Hirsch, Paris
• 16:35-17:00: Succeeding the translation for remyelinating therapies in MS
  Bruno Stankoff, Paris

Conclusion by Étienne Hirsch, Director, ITMO NNP